MedTrace Logo

Cost-Effectiveness in Bladder Cancer

NCT00126958 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2009-02-19

No results posted yet for this study

Summary

This randomized clinical multicentre trial aims to evaluate the efficacy of microsatellite analysis on voided urine to detect tumour recurrences in the follow-up of patients with superficial urothelialcell carcinoma (UCC). Further, this study aims to identify subgroups of patients with a low risk of tumour recurrence using clinico-pathologic tumour characteristics in combination with a genetic marker (FGFR3 gene), such that the frequency of follow-up contact can be reduced. The overall objective is to reduce the frequency of cystoscopy during follow-up in patients with superficial UCC, leading to an improvement in quality of life at equal or lower costs. This study evaluates the cost-effectiveness of follow-up in bladder cancer.

Conditions

Interventions

PROCEDURE

urinary analysis

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • Reinier de Graaf Groep

    collaborator OTHER

  • Sint Franciscus Gasthuis

    collaborator OTHER

  • Vlietland Ziekenhuis

    collaborator OTHER

  • Medisch Centrum Rijnmond-Zuid, Netherlands

    collaborator OTHER_GOV

  • Havenziekenhuis

    collaborator OTHER

  • Albert Schweitzer Hospital, Netherlands

    collaborator UNKNOWN

  • Ikazia Hospital, Rotterdam

    collaborator OTHER

  • Leiden University Medical Center

    collaborator OTHER

  • Erasmus Medical Center

    lead OTHER

Principal Investigators

  • Th. van der Kwast, Prof PhD MD · Erasmus MC, JNI

  • E.C. Zwarthoff, Ph.D · Erasmus MC, JNI

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-07-31
Completion
2005-07-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00126958 on ClinicalTrials.gov